Iraqi Journal of Veterinary Sciences

Ovario-utero protective effect of silymarin in ethidium bromide treated female rats

H.G. Abdulshaheed¹, J.A. Al-Sa’aidi² and J.K. Al-Arak³

¹Department of Animal Production, College of Agriculture, ²Department of Biochemistry, Physiology and Pharmacology, College of Veterinary Medicine, University of Al- Qadisiyah, Al- Qadisiyah, ³Department of Biochemistry, Physiology and Pharmacology, College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq

hayder.abdulshaheed@qu.edu.iq, 0000-0002-6710-7449

jabbar.alsaadi@qu.edu.iq, 0000-0003-2022-2287, Corresponding

jawad.k@covm.uobahdad.edu.iq

Abstract

This study was conducted to qualify the ameliorating potency of silymarin against toxicity in ethidium bromide (EtBr) treated female rats. Eighty female Wistar rats aged 100 days, weighted 170-175 g were randomly allocated to control, orally supplemented with drinking water, and three treated groups, orally supplemented with silymarin 200 mg/kg BW, EtBr 10 mg/kg BW, and combination of EtBr and silymarin (SEtBr), respectively. Each group was allocated to two subgroups, sacrificed after 20 and 40 days of treatment. Bodyweight gain, uteri, and ovaries weight were recorded. Ovarian samples were obtained for histopathological examination. EtBr group females recorded the lowest body weight gain, relative weights of ovaries and uteri, and ovarian follicle number, whereas S group females recorded the highest body weight gain and follicular number, while the ovaries and uteri weights were either higher or close to the control group, at both experimental periods. Histopathological findings of both periods revealed necrosis, cirrhosis, ischemia, and prominent hemorrhage in the blood capillaries in EtBr treated ovarian tissues, but many of the ovarian follicles being mature and the atretic follicles were hence found to be high in number, whereas silymarin treated females showed normal ovarian tissues and viable ovarian follicles as that in control females. The combination-treated females, at 20 days, revealed necrotic primary ovarian follicles with some macrophages infiltration, whereas 40 days’ period showed normal ovarian cortex, medulla, and ovarian follicles. In conclusion, silymarin treatment in combination with EtBr has a potent amelioration effect against ovarian toxicity, in a duration-dependent manner.

Keyword: Ethidium Bromide, Silymarin, Stress, Ovaries, Uteri

التأثیر الوقائی للسیلیمارین على مبایض وأرحام إناث الجرذان المعاملة ببرومید الإیثیدیوم

حیدر غازی الفتلاوی1، جبار عباس أحمد الساعدی2 و جواد کاظم العراک3

1 قسم الإنتاج الحیوانی، کلیة الزراعة، 2فرع الکیمیاء الحیاتیة، والفسلجة والأدویة، کلیة الطب البیطری، جامعة القادسیة، الدیوانیة، 3فرع الکیمیاء الحیاتیة، والفسلجة والأدویة، کلیة الطب البیطری، جامعة بغداد، بغداد، العراق

الخلاصة

أجریت هذه الدراسة لتقییم فاعلیة السیلیمارین المحسنة ضد السمیة فی إناث الفئران المستحثة ببرومید الإیثیدیوم. تم توزیع 80 أنثى جرذ ناضجة بعمر 100 یوم ومعدل وزن 170-175 غم بشکل عشوائی إلى مجموعة سیطرة جرعت ماء الشرب، وثلاث مجموعات معاملة، جرعت الأولى معلق السیلیمارین بجرعة 200 ملغم/ کجم من وزن الجسم، وجرعت الثانیة محلول برومید الإیثیدیوم بجرعة 10 ملغم/ کغم من وزن الجسم، وجرعت الثالثة بمزیج برومید الإیثیدیوم والسیلیمارین. تم تقسیم کل مجموعة إلى مجموعتین ثانویتین، تمت التضحیة بها بعد 20 و 40 یوما من المعاملة. تم تسجیل معدل الکسب الوزنی وأوزان المبایض والأرحام. کما أخذت عینات من المباض والأرحام لدراسة التغیرات النسجیة المرضیة. سجلت المجموعة المعاملة ببرومید الایثیدیوم اقل زیادة فی وزن الجسم والأوزان النسبیة للمبیض والرحم وأعداد الجریبات المبیضیة بینما سجلت المجموعة المعاملة بالسیلیمارین اعلى زیادة لوزن الجسم وأعداد الجریبات المبیضیة فی حین کانت الإوزان النسبیة لمبایض وأرحام لمجموعة المعاملة بالاثنین معا أعلى أو قریبة من مجموعة السیطرة فی مرحلتی الدراسة. بین الفحص النسیجی تغیرات مرضیة فی نسیج المبیض لمجموعة تمثلت بالنزف والتنکس فی خلایا المبیض مع تشمع ونقص الأوکسجین بالإضافة إلى التحلل والتنکس الشدید ووصول عدد قلیل من الجریبات لمرحلة النضج مع وجود تحطم کامل لبعض الجریبات. بینما اظهر الفحص النسیجی لمقاطع المبیض من مجموعتی السیطرة والسیلیمارین نسیجا طبیعیا وعدم وجود نزف أو التهابات فی الجریبات المبیضیة، بینما أظهرت مجموعة فی مرحلة 20 یوما تنکسا فی بعض الجریبات الابتدائیة مع ارتشاح الخلایا البلعمیة فی حین أظهرت المبایض فی مرحلة 40 یوما قشرة ولبا طبیعیین. یستنتج من نتائج الدراسة الحالیة أن المعاملة بالسیلیمارین دورا وقائیا عند إعطائه مع برومید الإیثیدیوم فی تخفیف الآثار السمیة لمبایض وأرحام إناث الجرذان. 

Introduction

The ovary is a major reproductive gonad that functions as an endocrine gland in addition to being exocrine gland. Any defects that occur in the structure and function of the ovaries leads to a defect in the reproductive function in the mammals, as the ovaries produce oocytes in addition to the production of sex hormones, mainly estrogens (1). Ethidium Bromide (EtBr) is considered as one of the toxicant sources in the laboratories, acts as an intercalating agent and is broadly used as a stain and a nonradioactive marker in molecular biology laboratory techniques (2). It has been used in treatment of trypanosomiasis in cattle (3). According to Environmental Health and Safety, EtBr is considered as a potent mutagen, where it acts by intercalating the double stranded DNA and deforms its structure, which inhibits DNA duplication and interrupts protein biosynthesis by inhibiting mitochondrial-associated RNA. as EtBr is considered as a toxic and dangerous due to its potency as a mutagenic or teratogenic agent, where it increased glycolytic activity, increased oxidative stress, and mitochondrial ultrastructural changes (4). Silymarin, the main flavonoid and active ingredient of Silybum marianum (milk thistle) fruit and seeds, is considered as a natural antioxidant, which has been commonly used as a phytotherapy for several medicinal applications such as liver disorders (5). Silymarin contain five active polyphenolic components, silibins and isosilibins, silychristin, silydianin, and isosilychristin as well as one flavonoid (taxifolin) which is a constituent present in the fruits, leaves and seeds of milk thistle, among them silibin is the most active therapeutic potent (6). In many studies, silymarin and silibin are used in human as hepatoprotective substances, where it has been found that silymarin provide significant protection against experimental hepatotoxicity in laboratory animals. Their effects are related mainly to the anti-oxidative (7), analgesic (8) anti-lipid peroxidative mechanisms, antidiabetic, and hepatoprotective effects (9). 

This study aims to examine the ameliorating potency of silymarin against toxic effects of EtBr on female rat ovarian and uterine structure and function. 

Materials and methods

Preparation of silymarin suspension

Silybum marianum seeds were obtained from the Iraqi local market. The seeds were grinded by electrical grinder. To get the dose of 200 mg/ kg bw (10), the seed powder was suspended in drinking water (40 g/ L or 20 mg/ 0.5 ml). The rats were supplemented with 0.5 ml of suspension/ 100g bw.

Experimental animals

According by guidelines of ethics and policies of the university of Al-Qadisiyah, the current study was conducted by using 80 adult virgin cycling female Wistar rats (aged 100 days and weighted 170- 175 g). The females were housed in a well-controlled hygienic environmental condition (daylight cycles 12L: 12D and temperature around 22-24°C), fed laboratory food pellets (19% protein and 3000 kcal.) and water ad libitum. The females were used only with perfect estrous cycles. The method which has been to determine the estrus phases was described by Marcondes et al. (11).

Experimental design

Eighty females were randomly divided to four experimental groups (20 females each). Control group (C) was supplemented with 0.5 ml/ kg bw. of drinking water for 40 days, whereas silymarin treated group (S) was supplemented with silymarin 200 mg/kg bw for 40 days, EtBr treated group (EtBr) was supplemented with EtBr 10 mg/kg/day for 40 days, and combination treated group (SEtBr) was supplemented with both of silymarin and EtBr for 40 days. After 20 and 40 days of treatment, 10 females from each group were weighed and anesthetized by 0.3 ml Ketamine and 0.1 ml of Xylazine/ kg BW. Ovaries and uteri were obtained and weighted. Ovaries and uteri were incubated fixative solution (10% alcohol-formalin) for histological study (12).

Statistical analysis

The results were stated as mean ± standard deviation where means were compared by ANOVA-1 and Newman- Keuls (13). In the current study, P

Results

Body weight gain and relative weights of ovaries and uteri

The finding stated in table 1 represent significant (P≤0.05) upsurge of body weight gain in control, S and SEtBr groups started at 20 d. and continued at 40 d., whereas EtBr treated group recorded insignificant (P≥0.05) changes among treatment periods. In comparison among groups for each period, S group females recorded the highest elevation (P≤0.05) of weight gain, whereas EtBr group females recorded the lowest elevation (P≤0.05), at both periods. However, SEtBr group body gain was lower (P≤0.05) than control, at both periods. The data showed a significant decrease (P≤0.05) of relative ovarian weight in EtBr treated females among experimental groups at 20 d. period, whereas 40 d. period showed increment (P≤0.05) of that S group among experimental groups. SEtBr group recorded insignificant (P≥0.05) changes compared with control, whereas EtBr females registered the lowest significant (P≤0.05) ovarian weight in comparison with other groups. In comparison between the two periods for each group, the results revealed insignificant (P≥0.05) changes between periods. Relative uterine weights of S females (Table 1) revealed insignificant (P≥0.05) elevation, at 20 d. period, and significant (P≤0.05) elevation, at 40 d. period, in comparison with control, but it was higher than that of SEtBr and EtBr females (P≤0.05), at both periods. On the other hand, the two periods revealed insignificant (P≥0.05) changes of uteri weights of control, S and SEtBr groups, but EtBr females reported significantly (P≤0.05) decline, only at 40 d. period.

Table 1: Relative ovarian and uterine weights of EtBr induced female rats treated with silymarin

C group: drenched with drinking water. S group: daily supplemented with silymarin suspension (200 mg/kg). EtBr group: daily drenched with EtBr solution (10 mg/kg). SEtBr: daily drenched with EtBr solution (10 mg/kg) plus silymarin (200 mg/kg). Data were stated as Mean ±SD. Significancy between groups (P≤0.05) was presented as different small letters, whereas that between periods was presented as different capital letters.

Ovarian morphometry

At 20 d. period, ovarian diameter of S and SEtBr group females showed insignificant (P≥0.05) differences, while that of EtBr females decreased significantly (P≥0.05) compared with that of control, S, and SEtBr group females. At 40 day period, S group females recorded the highest (P≥0.05) ovarian diameter and EtBr group females recorded the lowest (P≥0.05) ovarian diameter among studied groups, whereas control and SEtBr group females showed insignificant (P≥0.05) difference at this period. Significant (P≥0.05) increase of ovarian diameter was shown at 40 d. period than 20d. period, in all groups except EtBr group which showed insignificant (P≥0.05) changes (Table 2).

Uterine morphometry

At both experimental periods, uterine endometrium thickness of S and SEtBr females reported insignificant (P≥0.05) changes whereas EtBr females recorded significant (P≤0.05) decrease than control females, at 40 d. period only. In comparison among experimental periods, all groups reported insignificant (P≥0.05) changes (Table 2). In comparison between experimental group female rats for each period or between experimental periods for each group, insignificant changes were shown in the uterine myometrium thickness (Table 2).

Table 2: Ovarian and uterine morphometry of EtBr induced female rats treated with silymarin

C group: drenched with drinking water. S group: daily supplemented with silymarin suspension (200 mg/kg). EtBr group: daily drenched with EtBr solution (10 mg/kg). SEtBr: daily drenched with EtBr solution (10 mg/kg) plus silymarin (200 mg/kg). Data were stated as Mean ±SD. Significancy between groups (P≤0.05) was presented as different small letters, whereas that between periods was presented as different capital letters.

Primary follicles

At 20 d. periods, the number of primary follicles of control and SEtBr group females showed insignificant (P≥0.05) changes while that of EtBr females recorded significant (P≤0.05) decrease than control, S, and SEtBr group females. At 40 d. period, S group females recorded the highest number (P≤0.05) among studied groups followed by control group and then SEtBr group, whereas EtBr group recorded the lowest significant (P≤0.05) number. When comparing between experimental periods, S females recorded significant (P≤0.05) increase whereas SEtBr and EtBr group females recorded significant (P≤0.05) decline in the number at 40 d. period compared with 20 d. period (Table 3).

Secondary follicles

At both experimental periods, the number of secondary follicles of S, control and SEtBr groups reported insignificant (P≥0.05) changes while EtBr group recorded significant (P≤0.05) decrease than all other groups. When comparing between studied periods, all groups reported insignificant (P≥0.05) changes in the ovarian diameter (Table 3).

Graffian follicles

The result of the Graffian follicle number, clarified in table 3, revealed elevation (P≤0.05) in silymarin treated females and decline (P≤0.05) in EtBr treated females in comparison with control females, at both experimental periods, whereas a combination treatment (SEtBr) revealed insignificant (P≥0.05) changes compared with control. On the other hand, all studied groups showed insignificant (P≥0.05) changes among the two periods.

Total ovarian follicles

As illustrated in table 3, the total number of ovarian follicles in S group females elevated significantly (P≤0.05) than control females, and those treated with EtBr declined significantly (P≤0.05) than control females, at both experimental periods, whereas that of SEtBr females revealed insignificant (P≥0.05) changes compared with control. On the other hand, all studied groups showed insignificant (P≥0.05) changes among the periods.

Table 3: Number of ovarian follicles of EtBr induced female rats treated with silymarin

C group: drenched with drinking water. S group: daily supplemented with silymarin suspension (200 mg/kg). EtBr group: daily drenched with EtBr solution (10 mg/kg). SEtBr: daily drenched with EtBr solution (10 mg/kg) plus silymarin (200 mg/kg). Data were stated as Mean ±SD. Significancy between groups (P≤0.05) was presented as different small letters, whereas that between periods was presented as different capital letters.

Histopathological changes in ovaries

Twenty days treatment period of Ethidium bromide treated female rats showed sever hemorrhage and necrosis of the ovarian tissues, particularly in the granulosa cells and secondary follicles, cirrhosis, and ischemia (Figure-1: C and D), but mostly viable and intact oocytes and cortical tissue surrounded by stroma is shown. Silymarin treated female rats (Figure-1: E and F) showed normal tissue and normal secondary follicle layers, theca interna, zona granulose, antrum, zona pellucid and oocyte in comparison with control (Figure-1: A and B). Furthermore, the total number of atretic follicles was hence found to be higher in Ethidium bromide treated ovarian tissues as compared with control and silymarin treated groups. Ovarian tissues from combination treated female rats (Figure-1: G and H) showed mixture of intact and necrotic ovarian cortex and medulla, necrotic primary follicles but some of the ovarian follicles still viable, and infiltration of some macrophages are also shown. Forty days treatment period of Ethidium bromide treated female rats (Figure-2: C and D) revealed pronounced degenerative changes in ovarian texture. Furthermore, sloughing, cytolysis and general necrosis and vaculation are shown in the follicles. Few number of mature follicles were seen. Furthermore, a complete destructed follicle also seen in this group. Silymarin treated female rats (Figure-2: E and F) and control female rats (Figure-2: A and B) showed normal ovarian tissues and normal follicular layers, theca interna, zona granulose, antrum, zona pellucid and oocyte. Ovarian tissues from combination treated female rats (Figure-2: G and H) showed showed normal ovarian tissue (primary cortex and medulla), all the ovarian follicles are viable and no hemorrhage or inflammation is seen.

Figure 1: Ovarian sections from 20 days period. A and B: Control ovary shows normal ovarian cortex (black arrow) and viable primary (yellow arrow) and secondary (white arrow) follicles, H&E, X100 and X400, respectively. C and D: EtBr treated ovary shows severe hemorrhage (blue arrows) and necrosis (white arrows), necrosis of granulosa cells (yellow arrow) of the secondary follicle (black arrow) but mostly viable and intact oocytes and cortical tissue surrounded by stroma, H&E, X100 and X400, respectively. E and F: Silymarin treated ovary shows normal tissue and normal secondary follicle layers, theca interna (blue arrow), zona granulose (white arrow), antrum (yellow arrow), zona pellucid (black arrow) and Oocyte (O). H&E, X400. G: Combination treated ovary shows mixture of intact (white arrows) and necrotic (black arrows) ovarian cortex and medulla, but some of the ovarian follicles still viable (yellow arrow). H&E, X100. H: Combination treated ovary shows necrotic ovarian tissue (yellow arrows), necrotic primary ovarian follicle (white arrow) and infiltration of some macrophages (black arrows). H&E, X400.

Figure 2: Ovarian sections from 40 days period. A and B: Control ovarian tissue Shows normal ovarian cortex (black arrow) and medulla (blue arrow), also presence of normal ovarian follicles (yellow arrows) and viable ovarian follicles (white arrows), H&E, X100 and X400, respectively. C: EtBr treated ovary shows complete destruction and necrosis of some ovarian follicles (black arrow), as well as wide spread necrosis of medulla (NM) and corpus luteum (CL), mature necrotic and vacculated (white arrows) graafian follicle (GF), and atretic follicle (EF) are obvious in the section surrounding by stroma. H&E, X100. D: EtBr treated ovary shows complete destruction and necrosis of some ovarian follicles (black arrow). H&E, X400. E and F: Silymarin treated ovary shows normal ovarian tissue (primary cortex and medulla) and there are primary and secondary follicles, H&E, X100 and X400, respectively. G and H: Combination treatment ovary shows normal ovarian tissue (cortex and medulla) and there are primary and secondary follicles (white arrows) no hemorrhage or inflammation is seen, H&E, X100 and X400, respectively.

Histopathological changes in uteri

Twenty days treatment period, uterine tissues of Ethidium bromide treated female rats revealed pathological changes including endometritis and presence abundant plasma cells, which is a diagnostic feature of endometritis (Figures 3: C and D) when compared with silymarin treated female rats (Figures 3: E and F) and control female rats (Figures 3: A and B), where these groups shared the same normal uterine lining epithelial tissue and normal uterine glands. The results showed a protective effect of the silymarin against the ethidium bromide toxicity, where the uterine tissue, including epithelial lining, strromal cells and uterine glands are still viable and normal during this period of the experiment (Figures 3: G and H). Forty days treatment period, uterine tissues of Ethidium bromide treated female rats showed chronic endometritis and and abundant infiltration of plasma cells beneath the epithelial tissue (Figures 4: C and D) compared with silymarin treated females (Figures 3: E and F) and control female rats (Figures 3: A and B), where these groups shared normal uterine lining epithelial tissue and normal uterine glands. The combination treated group confirmed the protective effect of silymarin on the uterus, where the uterus tissue revealed no observed pathological changes and all uterine layers still normal and viable (Figures 4: G and H).

Figure 3: Uteri sections from 20 days period. A and B- Control uterus tissue shows normal uterine tissue, the epithelial lining is normal (white arrow), and the uterine glands (black arrow), H&E, X100 and X400, respectively. C- and D- EtBr treated uterus shows endometritis (black arrow) and abundant plasma cells (white arrows) which is a diagnostic feature of endometritis H&E, X100 and X400, respectively. E- and F- Sylimarin treated uterus shows normal uterus tissue shows normal simple columnar tissue of the endometrium and normal uterine glands H&E, X100 and X400, respectively. G- and H- Combination treated uterus shows normal uterine tissue, the epithelial lining is normal (white arrow), also the uterine glands (black arrow). H&E, X100 and X400, respectively.

Figure 4: Uteri sections from 40 days period. A and B- Control uterus tissue shows Normal uterus tissue shows normal simple columnar tissue (white arrows) and normal uterine glands, H&E, X100 and X400, respectively. C- and D- EtBr treated uterus shows chronic endometritis (X100) and presence abundant plasma beneath epithelial layer in the stroma (X400) as well as abundant plasma cells (white arrows) which is a diagnostic feature of endometritis, H&E, X100 and X400, respectively. E- and F- Sylimarin treated uterus shows normal uterine tissue, normal simple columnar tissue (white arrows) and normal uterine glands (black arrows), H&E, X100 and X400, respectively. G- and H- Combination treated uterus shows normal uterine tissue, the epithelial lining is normal (white arrow), also the uterine glands (black arrow), H&E, X100 and X400, respectively.

Discussion

The significant increase in the body weight gain of silymarin treated groups might be attributes to the stabilization action of silymarin to the hepatocytes membranes, which exerted protection to the hepatocytes and improved liver function. Moreover, the stimulatory action of RNA and protein synthesis shown by silymarin could be subsequently improved growth and increased body weight gain (14). Furthermore, many researchers have suggested the stimulatory action of silymarin by increasing the transcription of ribosomal RNA. Elevated ribosomal production and accelerated protein and DNA biosynthesis could be improving the biosynthesis of structural and functional proteins. Moreover, the stimulatory effect of silymarin may offer more transporters and enzymes, which could enhance different body cells functions (14). Decreased body weight gains in EtBr treated female rats might be associated with the increased oxidative stress, since EtBr toxicity leads to cellular antioxidant defense capacity overloading. At this time, reactive oxygen species begin to attack the cellular macromolecules such as DNA, lipids and proteins in addition to cellular amino acids stores (15). Therefore, the alteration of oxidative status will significantly oxidize the amino acids pool, whereas lipids and proteins will be significantly affected in parallel with cytotoxicity. Conversely, improvement achieved by the protection role of silymarin against EtBr toxicity, in combination treatment group. This might be due to the means of the stable antioxidant activities of both sets of enzymatic and non-enzymatic antioxidants. Accordingly, significant body weight gain improvement achieved in both groups that treated with silymarin.

Improvement of ovarian and uterine weights of silymarin treated groups in this investigation might be attributes to the improvement of pituitary-gonadal axis. Askaripour et al. (16) mentioned that the gonadotrophic-like effects of many herbal extracts can perform many biological actions, including elevated ovarian and uterine relative weight, induction of ovulation, and stimulation of steroidogenic and protein biosynthesis pathways. Moreover, it has been stated that the natural antioxidants of herbal sources have a modulatory effect to treat abnormal hormone secretions accompanying with oxidative stress (17), where the previous findings revealed potent activity of silymarin as an antioxidant which could directly scavenge the increased free radicals caused by EtBr repro-toxicity, inactivate them, and repair the damage (18). Furthermore, this result might be attributes to the role of silymarin to increase ovarian estrogen production, as ovarian sex hormones (estradiol and progesterone) work together in a precise and coordinated mechanism in the control of ovarian functions, including folliculogenesis, oogenesis, the estrous cycle, sexual behavior and ovulation, as the biosynthesis and action of the hormones can be modified by endogenous and/or exogenous factors (19). In the present study, EtBr has been investigated as an exogenous stressful factor, which could play as an inhibitory effector on hypothalamus-pituitary-ovarian axis, whereas silymarin has been investigated alone or in combination with EtBr, as an exogenous ameliorating factor, which could play as a stimulatory effector on hypothalamus-pituitary-ovarian axis.

The positive role of silymarin reflected on the size and number of growing and total ovarian follicles, that shown in silymarin treated group, however EtBr treated group showed opposite results. Previous reports mentioned that oxygen deprivation is important to stimulate follicular angiogenesis and thus adequate follicular growth and development of the ovaries, in contrast follicular reactive oxygen species promotes apoptosis (20). The role of silymarin, in S and SEtBr groups, could be causes improvement of GSH and FSH levels, which could be counterbalances the free radicals in the growing follicle. Moreover, this could be associates with estradiol secretion and therefor increases the response of ovarian granulosa cells to FSH, which could trigger catalase production in the ovarian follicles, and preventing apoptosis (20). In EtBr treated females, the antioxidant depletion could be a result of excessive oxidative stress and this status could leads to lipid peroxidation which in turn could affect the production of estrogen from ovarian follicles. Supplementation of EtBr, therefor, could decrease the production of glycoproteins and steroid hormones from the ovarian follicles, which might causes infertility. Previously reported, in mammals, that structural proliferation of gonadal and uterine tissues has been detected after treatment with estrogenic activity flavonoids (21). These results were in agreement with the present results since uterine endometrial epithelium showed hypertrophy with tall columnar cells and the size and the number of uterine glands have increased. These observations accompanied by increased number of Graffian follicles and total ovarian follicles.

The decline of relative ovarian weight in EtBr treated group could be due to the toxic effect of EtBr, where it increases the oxidative stress. This declined of ovarian weight was associated with histopathological changes, including necrosis, degeneration, ischemia and pronounced hemorrhage of the ovary. Other ovarian sections revealed marked degeneration of ovarian histological architecture. These pathological alterations could be due to nuclear degeneration, chromatolysis, rupture and dissolution of nuclear membrane. Mitochondria DNA impairment could be a result of increased reactive oxygen species levels, as mitochondrion is the main site of ROS production (22). Due to the high number of mitochondria and high mitotic activity of granulosa cells, it can be hypothesizes that mitochondrial damage will lead to elevated reactive oxygen species and induction of oxidative stress (20). So elevated reactive oxygen species associated mitochondrial damage due to EtBr treatment may be implicates in cell apoptosis or decreased granulosa cell division during folliculogenesis. Silymarin act as an exogenous antioxidant and inducer of endogenous antioxidants by away of concentration-dependent (23). Previous studies mentioned that the protective efficiency of silymarin could be attributes to its disability of the cycle of cyclooxygenase and leukotriene actions (20). Also, the phenolic property of silymarin acts to stabilize the free radicals and ROS by donation them electron and therefor preventing lipo-peroxidation by assistance the communication with cellular non-enzymatic antioxidants (24). A developed antioxidant system has been found in the reproductive organs (25), particularly gonads, where this antioxidants have a vital role in protecting reproductive tissues against free radicals and, in turn, preventing their negative effects on reproduction (20). On the other hand, different herbal extracts and herbal-derived substances have protective effects in the reproductive system. From these herbal extracts, Silymarin was considered as a potent antioxidant agent that can protect most of the biological tissues, including reproductive tissues, such as germ cells (25).

Conclusion

In conclusion, EtBr can be responsible for the ovarian and reproductive dysfunction, due to induction of oxidative stress. On the other hand, the harmful action of this toxicity however can be counteracted by induction of endogenous antioxidants or supplementation of exogenous antioxidants. In this study, silymarin has shown beneficial detoxifying activities including improvement of ovarian structure and function.

Acknowledgments

We would like to thank the deanery of the College of Veterinary Medicine, University of Al-Qadisiyah who allowed us to conduct our study experiments in their animal house. Also many thanks to Assist. Prof. Dr. Hasan Khalaf for his kind assistance in the histopathological examination.

Conflict of interest

We certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Article highlights

1. The toxic role of ethidium bromide on the female reproductive organs.
2. The role of silymarin in moderating toxicity of the female reproductive system.
3. The efficiency of the ovaries due to the treatment with silymarin.

• Article View: 435
• PDF Download: 227